SEC 13F Intelligence

Global Imc LLC / SRPT

Global Imc LLC’s Sarepta Therapeutics Inc Position

Does Global Imc LLC own Sarepta Therapeutics Inc (SRPT)? Not currently — the last reported position was 29.1K shares worth $4M in Q1 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q1 2023
Shares
29.1K
% of Portfolio
+1.13%
Quarters Held
3
position exited

Position History SRPT

Reported value by quarter
Q3 ’22: $2MQ3 ’22Q4 ’22: $2MQ4 ’22Q1 ’23: $4MQ1 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202329.1K$4M+1.13%
Q4 202214.3K$2M+0.48%
Q3 202220.5K$2M+0.60%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Global Imc LLC’s full portfolio or all institutional holders of SRPT.